Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, kinetics, biodistribution, and repeatability of the radiotracer 11C-BMS-986196 after IV administration in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• 11C-BMS-986196

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Sclerosis (MS) | Phase 1 | Status: TERMINATED | Results posted: 2025-04-24